| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |